Article Information
History
- July 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Min Ho An, MD1,4,*,
- Min Seo Kim, MD2,5,*,
- Yu-Kyung Park, MD3,
- Bong-Ok Kim3, MD, PhD,
- Seok Ho Kang9, MD, PhD,
- Won Jun Kim, MD2,
- Sung Kyu Park, MD3,
- Hea-Woon Park, MD, PhD3,
- Wonjong Yang, MD3,
- Joonyoung Jang, MD3,
- Soon-Woo Jang, MD, KMD6,10,† and
- Tae-Ho Hwang, DSS, PhD7,8,†
- 1Ajou University, School of Medicine, Suwon, Republic of Korea
- 2Korea University, College of Medicine, Seoul, Republic of Korea
- 3Korea Workers’ Compensation & Welfare Services Daegu Hospital, 515 Hakjeong-ro, Buk-gu, Daegu, Republic of Korea
- 4Director of So Ahn Public Health Center, Wando, Republic of Korea
- 5Director of Cheongsan Public Health Center, Wando, Republic of Korea
- 6Director of Bukha Public Health Center, Jangseong, Republic of Korea
- 7Department of Pharmacology, Pusan National University, School of Medicine, Yangsan, Republic of Korea
- 8Gene and Cell Therapy Research Center for Vessel-associated Diseases, School of Medicine, Pusan National University, Yangsan, Republic of Korea
- 9Department of Urology, Korea University, School of Medicine, Seoul, Republic of Korea
- 10Pusan University, School of Medicine, Yangsan, Republic of Korea
- ↵†Corresponding author:
Soon-Woo Jang, MD, KMD, Pusan University, School of Medicine, Yangsan, Republic of Korea, Director of Bukha Public Health Center, Jangseong, Republic of Korea, Phone: +82-10-88994593, E-mail: kmedicsoon{at}gmail.com, Tae-Ho Hwang, DSS, PhD, Department of pharmacology, Pusan National University, School of Medicine, Yangsan, Republic of Korea, Director of Gene and Cell Therapy Research Center for Vessel-associated Diseases, School of Medicine, Pusan National University, Yangsan, Republic of Korea, Phone: +82-10-71579950, E-mail: thhwang{at}pusan.ac.kr
↵* two authors contributed equally to this work
Posted July 07, 2020.
Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos